Discover

INTS
Intensity Therapeutics, Inc.
4.15
2 x 2.96
2 x 5.37
bid
ask
+
0.05
1.22%
2 @ 05:21 AM
4.00 -0.15 (3.61%)
Ytd-59.51%
1y-46.10%
4.13
day range
4.20
3.51
52 week range
43.50
Open4.15Prev Close4.10Low4.13High4.20Mkt Cap11.22M
Vol59.63KAvg Vol38.66KEPS-4.01P/EN/AForward P/E-1.66
BetaN/AShort Ratio3.05Inst. Own12.49%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0750-d Avg4.50200-d Avg7.581yr Est10.00
Income Statement
Operating Expenses2.53M
Research and Development Expense1.20M
Selling, General and Administrative Expense1.33M
Operating Income-2.53M
Net Income-2.43M
Net Income Common Stock-2.43M
Net Income Common Stock (USD)-2.43M
Consolidated Income-2.43M
Earnings per Basic Share-0.96
Earnings per Basic Share (USD)-0.96
Earnings per Diluted Share-0.96
Earning Before Interest & Taxes (EBIT)-2.43M
Earning Before Interest & Taxes (USD)-2.43M
Weighted Average Shares2.53M
Weighted Average Shares Diluted2.53M
Balance Sheet
Cash and Equivalents10.25M
Cash and Equivalents (USD)10.25M
Current Assets10.91M
Property, Plant & Equipment Net89.00K
Total Assets12.29M
Total Debt70.00K
Current Liabilities2.24M
Debt Non-Current70.00K
Total Liabilities2.31M
Accumulated Retained Earnings (Deficit)-80.82M
Shareholders Equity9.98M
Shareholders Equity (USD)9.98M
Assets Non-Current1.39M
Total Debt (USD)70.00K
Liabilities Non-Current70.00K
Trade and Non-Trade Payables636.00K
Cash Flow
Depreciation, Amortization & Accretion7.00K
Net Cash Flow from Financing150.00K
Net Cash Flow / Change in Cash & Cash Equivalents-1.68M
Issuance (Purchase) of Equity Shares150.00K
Net Cash Flow from Operations-1.83M
Share Based Compensation387.00K